Belgium has solidified its position as a European leader in pharmaceutical research and development with a daily investment ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Though prescribing climate-friendly inhalers is environmentally sound, some experts warn certain patients may be overlooked.

At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and ...

CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

This eases the user's understanding of the market thoroughly, while also gaining knowledge about Anxiety Disorder Treatment market opportunities and the dominant players Pfizer Inc, Merck KGaA, Sanofi ...

Yet in Europe things look good for the firm ... Mark Hartley has positions in AstraZeneca Plc and GSK. The Motley Fool UK has recommended AstraZeneca Plc, GSK, Rolls-Royce Plc, Tesla, and Workday.

Barca’s success extends to the European stage: they have played in five Champions ... There is no main sponsor, as Bonmati ...

Good day and thank you for standing by. Welcome to the 23andMe fiscal year 2025 2nd quarter earnings call at this time. All participants are in listen-only mode. Please be advised that this call is ...

Europe’s high grade corporate bond market hosted a blowout day for borrowers, as peak orders for Volkswagen Financial ...